Eganelisib (IPI-549) Liposomes, Formulation WNX5.2
2995.00 €
In Stock
quantity
product details
Catalog number: 1142 - DLL-0015-A1-10ML
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: 10mL
DLL-0015-A1-10ML
Eganelisib (IPI-549) Liposomes, Formulation WNX5.2
PEGylated liposomes containing PI3Kγ inhibitor Eganelisib (IPI-549). Eganelisib (IPI-549) is a potent and selective PI3Kγ inhibitor (IC50 16 nM) which is reported to exhibit more than 100-fold selectivity over other lipid and protein kinases and potentiate immunotherapy with immune checkpoint inhibitors in mice. IPI-549 is insoluble in aqueous media. This product is a pre-formulated liposomal version of IPI-549 which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
2995.00 €
PN-0001-2ML
DOPC Liposomes
Pure DOPC liposomes, 30 mM, extruded and supplied sterile-filtered in glass vial.We synthesize custom liposomes like this. To see a full list of our formulation capabilities, click here.Or, contact us today to request a custom formulation.
450.00 €
PN-0002-10ML
DSPC Liposomes
Pure DSPC liposomes, 30 mM, extruded to 70-120 nm and supplied sterile-filtered in glass vial.We synthesize custom liposomes like this. To see a full list of our formulation capabilities, click here.Or, contact us today to request a custom formulation.
1200.00 €
PN-0002-2ML
DSPC Liposomes
Pure DSPC liposomes, 30 mM, extruded to 70-120 nm and supplied sterile-filtered in glass vial.We synthesize custom liposomes like this. To see a full list of our formulation capabilities, click here.Or, contact us today to request a custom formulation.